In vitro, treatment with anti-estrogens or knockdown of ERβ decreases the proliferation and invasion of bladder cancer cells, while overexpression of ERβ has the opposite effect [90, 91]. The gene discussed is ESR2; the disease is urinary bladder carcinoma.